Heart Failure Management

Indications and Usage

Diuretics are essential for relieving congestion and improving symptoms in patients with evidence of fluid retention or a prior history of fluid retention, particularly in heart failure management, as recommended by the American College of Cardiology and the American Heart Association 1, 2
The primary indication for diuretics is evidence of fluid overload/congestion, such as peripheral edema, pulmonary congestion, and jugular venous distension 1, 2
Diuretics should be used in combination with other guideline-directed medical therapy (GDMT) like ACE inhibitors, beta-blockers, and aldosterone antagonists, as suggested by the American Heart Association 2

Rapid symptom relief can be achieved within hours to days with diuretics, while other heart failure medications may take weeks to show effects, as noted by the American College of Cardiology 3
Options for diuretic therapy include furosemide, bumetanide, and torsemide, with specific dosage ranges, as suggested by the American College of Cardiology 1
The initial dose of furosemide should be 20-40 mg IV or oral daily, titrated based on response, as suggested by the European Heart Journal 4
Alternative loop diuretics include bumetanide (0.5-1.0 mg daily) and torasemide (5-10 mg daily), according to the European Journal of Heart Failure 5
Intravenous loop diuretics should begin in the emergency department without delay, with an initial IV dose that equals or exceeds the chronic oral daily dose, as recommended by the American College of Cardiology 3

Daily weight measurements, fluid intake and output, serum electrolytes, renal function, blood pressure, and heart rate, as well as clinical signs of congestion, should be monitored in patients receiving diuretics, as recommended by the European Heart Journal 6
Electrolyte abnormalities, such as hypokalemia, hyponatremia, and hypomagnesemia, can occur with diuretic use, according to the American Heart Association 2
Volume contraction can lead to hypotension and renal insufficiency, emphasizing the need for careful monitoring, as noted by the American Heart Association 2
Monitoring for electrolyte abnormalities, renal dysfunction, hypotension, and metabolic alkalosis is essential, with adjustments to diuretic doses as needed, as recommended by the European Heart Journal 6

Underdosing diuretics can lead to persistent fluid retention, which can diminish response to other heart failure medications, as warned by the American College of Cardiology 3
Overdosing diuretics can cause volume contraction, hypotension, and renal insufficiency, highlighting the importance of careful dosing, according to the American Heart Association 2
Monotherapy with diuretics in heart failure is not recommended, as diuretics alone cannot maintain clinical stability in heart failure patients and should be combined with other GDMT, as suggested by the American College of Cardiology 3
Loop diuretics are the first-line diuretic treatment for right-sided heart failure with severe pulmonary hypertension, with careful dosing to avoid excessive diuresis, as recommended by the European Society of Cardiology and the European Heart Society 4, 5
For patients with diuretic resistance, adding a thiazide diuretic (e.g., metolazone 2.5-10 mg daily or hydrochlorothiazide 12.5-50 mg daily) to a loop diuretic may be effective, as suggested by the European Journal of Heart Failure 5
Aldosterone antagonists (e.g., spironolactone 12.5-25 mg daily) can provide an additional diuretic effect while preserving potassium, as recommended by the European Heart Journal 5

If diuresis is inadequate, the diuretic regimen should be intensified through:
A sequential nephron blockade approach, with a loop diuretic, thiazide, and aldosterone antagonist, may be used for severe diuretic resistance, as suggested by the European Journal of Heart Failure 5

Transition to oral therapy should be done in all hospitalized patients with heart failure, with careful monitoring, with a level of evidence B 3
Discharge criteria include establishment of a stable and effective diuretic regimen, achievement of euvolemia, and definition of the patient's "dry weight", with a level of evidence C 7
Restriction of fluid intake to 2 liters per day and sodium intake to 2g per day or less is recommended, with a level of evidence C 7